As depicted in Fig. 1, for inclusion in this analysis, all participants in the depression groups were required to have a diagnosis of depression with or without third-trimester SRI treatment and with platelet 5-HT concentrations determined for both the mother and infant. Here, HTR5A is linked to depressive symptom measurement.